Mosaic neurofibromatosis type 1

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:634461Q85.0
Who is this for?
Show terms as
1FDA treatments1Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

Treatments

1 available

Koselugo

selumetinib· AstraZeneca / AlexionOrphan Drug

treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)

No actively recruiting trials found for Mosaic neurofibromatosis type 1 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mosaic neurofibromatosis type 1 community →

Specialists

1 foundView all specialists →
JC
Juliette Southworth, BS, CCRP
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Koselugo(selumetinib)AstraZeneca / Alexion

Travel Grants

No travel grants are currently matched to Mosaic neurofibromatosis type 1.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mosaic neurofibromatosis type 1Forum →

No community posts yet. Be the first to share your experience with Mosaic neurofibromatosis type 1.

Start the conversation →

Latest news about Mosaic neurofibromatosis type 1

No recent news articles for Mosaic neurofibromatosis type 1.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mosaic neurofibromatosis type 1

Which specialists treat Mosaic neurofibromatosis type 1?

1 specialists and care centers treating Mosaic neurofibromatosis type 1 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Mosaic neurofibromatosis type 1?

1 patient support program are currently tracked on UniteRare for Mosaic neurofibromatosis type 1. See the treatments and support programs sections for copay assistance, eligibility, and contact details.